Article Versions Notes

Rauwerdink DJW, Not Ov, de Meza M, Doorn Rv, Hage Jvd, Eertwegh AJMvd, Haanen JB, Aarts MJB, Berkmortel FWPJvd, Blank CU, et al. Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients. Cancers. 2024; 16(15):2656. https://doi.org/10.3390/cancers16152656

Rauwerdink, Daan Jan Willem, Olivier van Not, Melissa de Meza, Remco van Doorn, Jos van der Hage, A. J. M. van den Eertwegh, John B. Haanen, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Christiaan U. Blank, and et al. 2024. "Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients" Cancers 16, no. 15: 2656. https://doi.org/10.3390/cancers16152656

Rauwerdink, D. J. W., Not, O. v., de Meza, M., Doorn, R. v., Hage, J. v. d., Eertwegh, A. J. M. v. d., Haanen, J. B., Aarts, M. J. B., Berkmortel, F. W. P. J. v. d., Blank, C. U., Boers-Sonderen, M. J., Groot, J. W. B. d., Hospers, G. A. P., Piersma, D., van Rijn, R. S., Stevense-den Boer, A. M., Veldt, A. A. M. v. d., Vreugdenhil, G., Wouters, M. W. J. M., ... Kapiteijn, E. (2024). Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients. Cancers, 16(15), 2656. https://doi.org/10.3390/cancers16152656